Drug
DLBS3233 clinical trials
Also written DLBS3233.
- studies test it
- 6
- open now
- 1
- in phase 3
- 5
- first study started
- 2011
Keep track of what changes. Save the DLBS3233 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
6 studies that test it; most in 2011 (2)
| Year | Studies |
|---|---|
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2021 | 1 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 1
- Phase 3
- 5
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 5 · Other 1
Dexa Medica Group (5) · Inlacinpenelitian (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses DLBS3233 is read from its arms, and is right about nine times in ten.
Testing it · 6
- The Effect of Therapy Combination in PCOS With Dlbs 3233RecruitingEarly Phase 1InlacinpenelitianNCT07403201Written as dlbs 3233 , clomifen citrat
- PCOS Treatment Using DLBS3233, Metformin, and Combination of BothCompletedPhase 3Dexa Medica GroupNCT01999686Written as DLBS3233
- Efficacy and Safety of DLBS3233 in Subjects With Polycystic Ovary Syndrome (PCOS)CompletedPhase 3Dexa Medica GroupNCT01733459Written as DLBS3233
- Efficacy and Safety of DLBS3233 in Subjects With New Onset of Type 2 Diabetes MellitusCompletedPhase 3Dexa Medica GroupNCT01645332Written as DLBS3233
- Efficacy and Safety of Add-on Therapy With DLBS3233 in Patients With Type-2 Diabetes MellitusCompletedPhase 3Dexa Medica GroupNCT01472614Written as DLBS3233
- Efficacy and Safety of DLBS3233 in Prediabetic PatientsCompletedPhase 3Dexa Medica GroupNCT01531933Written as DLBS3233